Valuation: Abbott Laboratories

Market Cap 182B 160B 149B 137B 257B 17,443B 261B 1,762B 690B 8,622B 683B 668B 29,824B P/E 2026 *
29.9x
P/E 2027 * 23.1x
Enterprise Value 206B 181B 169B 155B 291B 19,760B 296B 1,996B 782B 9,767B 774B 757B 33,783B EV / Sales 2026 *
4.1x
EV / Sales 2027 * 3.72x
Free-Float
86.73%
Yield 2026 *
2.47%
Yield 2027 * 2.62%
1 week+1.66%
Current month+15.34%
1 month+15.34%
3 months+11.55%
6 months-22.75%
Current year-22.75%
1 week 101.66
Extreme 101.66
101.66
1 month 88.14
Extreme 88.14
101.66
Current year 82.56
Extreme 82.56
131.6
1 year 82.56
Extreme 82.56
131.6
3 years 82.56
Extreme 82.56
131.6
5 years 82.56
Extreme 82.56
131.6
10 years 82.56
Extreme 82.56
131.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+1.66% - - 182B
+3.16%+4.31%-6.52%-1.84% 108B
+2.71%+5.13%+10.06%+70.60% 60.54B
-4.21%-6.07%+22.50%+49.01% 50.53B
+4.67%+7.68%-10.24%-41.34% 43.79B
+2.04%+4.19% - - 33.57B
+2.02%-1.11%-15.89%-42.14% 28.31B
+1.74%-4.35%+27.89%-5.04% 23.31B
+5.47%+7.40%-0.05%+0.24% 21.28B
+1.78%+0.95%-11.55%+0.68% 20.27B
Average +1.58%-1.01%+2.02%+3.77% 43.27B
Weighted average by Cap. +0.76%-0.24%+1.57%+9.69%

Financials

2026 *2027 *
Net sales 50.3B 44.19B 41.23B 37.87B 70.94B 4,821B 72.17B 487B 191B 2,383B 189B 185B 8,243B 54.65B 48B 44.79B 41.14B 77.07B 5,238B 78.4B 529B 207B 2,589B 205B 201B 8,955B
Net income 6.25B 5.49B 5.13B 4.71B 8.82B 599B 8.97B 60.57B 23.73B 296B 23.48B 22.97B 1,025B 7.92B 6.96B 6.49B 5.96B 11.17B 759B 11.37B 76.72B 30.06B 375B 29.74B 29.1B 1,298B
Net Debt 24.17B 21.23B 19.8B 18.19B 34.08B 2,316B 34.67B 234B 91.67B 1,145B 90.72B 88.76B 3,960B 21.42B 18.81B 17.55B 16.12B 30.2B 2,053B 30.72B 207B 81.24B 1,015B 80.39B 78.66B 3,509B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change
26-07-27 US$101.66 0.00%
26-07-24 US$101.66 0.00%
26-07-22 US$101.66 0.00%
26-07-21 US$101.66 +1.66%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
104.49USD
Average target price
118.42USD
Spread / Average Target
+13.33%

Quarterly revenue - Rate of surprise